Therapeutic Areas
Market intelligence across 18 therapeutic areas, 237 indications, and 2,045+ tracked competitors.
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and proprietary databases. Refreshed daily.
Oncology
Solid tumors, hematologic malignancies, and immuno-oncology across all lines of therapy and modalities.
Neurology
Neurodegenerative diseases, movement disorders, epilepsy, and neuromuscular conditions spanning CNS and PNS.
Immunology
Autoimmune and inflammatory conditions including rheumatology, dermatologic, and systemic immune-mediated diseases.
Rare Disease
Orphan indications across genetic, metabolic, and ultra-rare conditions with significant unmet need.
Cardiovascular
Heart failure, atherosclerosis, hypertension, and cardiometabolic conditions.
Metabolic
Obesity, diabetes, NASH/MASH, and lipid disorders including GLP-1 and next-generation metabolic targets.
Psychiatry
Mood disorders, psychotic disorders, ADHD, substance use, and emerging psychedelic-assisted therapies.
Infectious Disease
Antiviral, antibacterial, antifungal, and vaccine programs including pandemic preparedness.
Hematology
Non-malignant blood disorders including hemophilia, sickle cell disease, thalassemia, and ITP.
Ophthalmology
Retinal diseases, glaucoma, dry eye, and gene therapies for inherited retinal dystrophies.
Pulmonology
Respiratory conditions including asthma, COPD, IPF, and cystic fibrosis.
Nephrology
Chronic kidney disease, IgA nephropathy, FSGS, and dialysis-related conditions.
Dermatology
Inflammatory and oncologic skin conditions, alopecia, and aesthetic dermatology.
Gastroenterology
IBD, IBS, celiac disease, and GI oncology including esophageal and gastric cancers.
Endocrinology
Thyroid disorders, growth hormone deficiency, adrenal insufficiency, and hypoparathyroidism.
Pain Management
Chronic pain, neuropathic pain, migraine, and non-opioid analgesic programs.
Urology
BPH, overactive bladder, erectile dysfunction, and urologic oncology.
Hepatology
Liver diseases including hepatitis B cure programs, PBC, PSC, and hepatocellular carcinoma.